4
Changes in Ownership
Atea Pharmaceuticals, Inc. Filed Acc 0000899243-20-030332
Director acquired 11,295 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Murphy Polly A. Director | 2020-11-03 | Conversion | +11,295 | 11,295 | I | ||
| Derivatives | |||||||
| Murphy Polly A. Director | 2020-11-03 | Conversion · Series D Convertible Preferred Stock | −7,122 | 0 | I | ||
| Murphy Polly A. Director | 2020-11-03 | Conversion · Series D-1 Convertible Preferred Stock | −4,173 | 0 | I | ||
Loading xslF345X03/doc4.xml…